Medicare Advantage
The Centers for Medicare & Medicaid Services yesterday announced proposed changes to the risk adjustment model for Medicare Advantage organizations and certain demonstrations for calendar year 2021.
Medicare Advantage organizations received $6.7 billion in risk adjustment payments in 2017 for diagnoses that were not supported by the medical record.
Priya Bathija, vice president of AHA’s The Value Initiative, talks with William Shrank, M.D., senior vice president and chief medical officer, Humana, to get his insights on health care affordability, value and the strategies that Humana is using to disrupt health care delivery.
The Centers for Medicare & Medicaid Services today published its star ratings for 2020 Medicare Advantage and prescription drug plans.
The Centers for Medicare & Medicaid Services today released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2020 calendar year.
The AHA today voiced support for the Improving Seniors’ Timely Access to Care Act (H.R. 3107), bipartisan legislation that would establish requirements for the use of prior authorization under Medicare Advantage plans.
AHA letter to Suzan DelBene regarding her work on the Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107), bipartisan legislation that would establish requirements for the use of prior authorization under Medicare Advantage plans.
The Centers for Medicare & Medicaid Services will discontinue the Medicare Advantage Qualifying Payment Arrangement Incentive Demonstration due to low participation, the agency announced last week.
The Centers for Medicare & Medicaid Services this week released final Medicare Advantage data on services provided to beneficiaries in calendar year 2015.
The Centers for Medicare & Medicaid Services May 16 released a final rule with the intent of lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.